Drug intelligence / Profile preview

hylan gf-20

Development stage
Phase 4
Lead developer
Sanofi
Modality
Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intraarticular
01

Overview

Hylan GF-20 is an elastoviscous, high molecular weight fluid composed of chemically crosslinked hylan A and hylan B polymers derived from hyaluronan (sodium hyaluronate), which itself is a naturally occurring polysaccharide found in joint synovial fluid. Hylans are produced from chicken combs. Hylan GF-20 acts as a viscosupplementation agent by mimicking the natural synovial fluid in the knee joint, providing lubrication and shock absorption. This helps reduce pain and improve mobility in patients with osteoarthritis of the knee who have not responded adequately to conservative non-pharmacologic therapy or simple analgesics such as acetaminophen. The product is administered via intra-articular injection directly into the affected knee joint[1][2][3][4][5].

Brand names
SynviscSynvisc-One
Other names
hylan g-f 20hylan polymers a and bhyaluronan crosslinked polymer

Beyond the preview

Go deeper on hylan gf-20.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hylan gf-20.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call